Neuroinflammatory and neurodegenerative aspects of Parkinson’s disease
The serum level of inflammatory markers, such as CCL5, slCAM-1, sVCAM-1, NCAM, PAI-1, and MPO, in PD patients varies depending on the stage of the progressive neurodegenerative process, indicating the importance of systemic inflammation during PD.
Authors
- Anastasiia S. Boiko (ORCID: https://orcid.org/0000-0002-2955-9057)
- М. С. Назаренко (ORCID: https://orcid.org/0000-0002-0673-4094)
- Л. А. Левчук (ORCID: https://orcid.org/0000-0003-1982-8492)
- М. А. Никитина (ORCID: https://orcid.org/0000-0002-2614-207X)
- В. М. Алифирова (ORCID: https://orcid.org/0000-0002-4140-3223)
- Svetlana А. Ivanova (ORCID: https://orcid.org/0000-0001-7078-323X)
- E. Yu. Bragina (ORCID: https://orcid.org/0000-0002-1103-3073)
Institutions
- Russian Academy of Sciences (RU)
- Mental Health Research Institute (AU)
- Siberian State Medical University (RU)
- Tomsk National Research Medical Center (RU)
Publication Details
- Journal
- S S Korsakov Journal of Neurology and Psychiatry
- Published
- 2025-04-08
- DOI
- https://doi.org/10.17116/jnevro2025125031102
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00